Edition:
United Kingdom

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

407.60GBp
16 Jan 2018
Change (% chg)

3.70 (+0.92%)
Prev Close
403.90
Open
402.00
Day's High
407.80
Day's Low
401.40
Volume
1,294,767
Avg. Vol
2,787,626
52-wk High
421.50
52-wk Low
246.50

Latest Key Developments (Source: Significant Developments)

Addex and Indivior Sign Strategic Partnership
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - ADDEX THERAPEUTICS LTD ::REG-ADDEX AND INDIVIOR SIGN STRATEGIC PARTNERSHIP TO ACCELERATE DEVELOPMENT OF GABAB PAMS AS ADDICTION TREATMENTS.UNDER TERMS OF AGREEMENT, ADDEX WILL RECEIVE $5 MILLION UPFRONT.UNDER TERMS OF AGREEMENT WILL RECEIVE $4 MILLION OF COMMITTED RESEARCH FUNDING OVER NEXT TWO YEARS.TO RECEIVE $330 MILLION OF POTENTIAL DEVELOPMENT.WILL RECEIVE REGULATORY AND COMMERCIALIZATION MILESTONES AND TIERED ROYALTIES UP TO DOUBLE-DIGIT.  Full Article

‍Indivior Says Repricing And Maturity Extension Of Term Loan Facilities
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - INDIVIOR PLC ::‍INDIVIOR ANNOUNCES REPRICING AND MATURITY EXTENSION OF TERM LOAN FACILITIES AND REPLACEMENT OF CREDIT FACILITY​.‍ENTERED AMENDMENT WITH VARIOUS LENDERS TO PROVIDE REPLACEMENT TERM LOAN FACILITIES IN AN AGGREGATE PRINCIPAL AMOUNT OF APPROXIMATELY $484 MILLION​.‍NEW TERM LOAN FACILITIES REDUCE GROUP'S INTEREST COUPON TO LIBOR PLUS 4.50% FROM LIBOR PLUS 6.00 PERCENT​.  Full Article

Indivior Announces NDA Acceptance Of RBP-7000 Risperidone Monthly Depot
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Indivior Plc ::INDIVIOR ANNOUNCES NDA ACCEPTANCE OF RBP-7000 RISPERIDONE MONTHLY DEPOT.FDA HAS SET A PDUFA TARGET ACTION DATE OF JULY 28, 2018.  Full Article

Indivior says Q3 net revenue $‍275​ mln vs. $268 mln
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Indivior Plc ::Q3 NET REVENUE $‍275​ MILLION VERSUS $268 MILLION A YEAR AGO.FY 2017 REVENUE AND NET INCOME GUIDANCE RECONFIRMED​.Q3 NET PROFIT $‍50 MILLION VERSUS LOSS OF $149 MILLION A YEAR AGO.SUBOXONE FILM MARKET SHARE AVERAGED 58 PCT IN YTD 2017 (YTD 2016: 61%).‍FINALIZING LAUNCH PLANS OF RBP-6000, WORKING WITH 3RD-PARTY MANUFACTURING PARTNERS TO APPROPRIATE DELIVERY TO ENABLE TARGET LAUNCH IN Q1 2018​.  Full Article

FDA committees recommend approval of Indivior's RBP-6000 for the treatment of opioid use disorder
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Indivior PLC :FDA advisory committees recommend approval of Indivior's RBP-6000 for the treatment of opioid use disorder.Indivior PLC - ‍FDA has set a prescription drug user fee act (PDUFA) target action date of November 30, 2017​.  Full Article

Old Mutual cuts stake in Indivior to 4.36 pct
Monday, 9 Oct 2017 

Oct 9 (Reuters) - Indivior Plc :OLD MUTUAL CUTS STAKE IN INDIVIOR TO 4.36 PERCENT FROM 7.01 PERCENT STAKE EARLIER- FILING‍​.  Full Article

Indivior says submitted NDA to FDA for schizophrenia​ treatment
Monday, 2 Oct 2017 

Oct 2 (Reuters) - Indivior Plc ::U.S. UNIT SUBMITTED NDA TO FDA ON SEPT. 28, TO SEEK MARKETING APPROVAL FOR RBP-7000, INDIVIOR'S TREATMENT OF SCHIZOPHRENIA​.  Full Article

Indivior to defend its position in U.S. anticompetitive practices lawsuit
Friday, 23 Sep 2016 

Indivior Plc : Indivior notified of civil complaint filed by State Attorneys General . Notified thirty-five U.S. States and District of Columbia filed a civil complaint alleging violations of state and federal antitrust and consumer protection laws .Company intends to continue to vigorously defend its position.  Full Article

Indivior announces intention to list ADRs in U.S.
Friday, 15 Jul 2016 

Indivior Plc : Intention to list ADRs in U.S. . Filed a registration statement on form 20-F with SEC . Each american depositary share is expected to represent five indivior ordinary shares. .Indivior is being advised by Covington & Burling LLP..  Full Article

Indivior wins U.S. patent suit on Suboxone film
Friday, 3 Jun 2016 

Indivior Plc : Indivior welcomes court ruling in anda litigation . Welcomes favourable ruling in district Court of Delaware in ANDA litigation against Actavis Laboratories Inc and Par Pharmaceutical . Ruling confirms Indivior's belief in validity and enforceability of its suboxone film patent portfolio .Ruling provides business with substantially greater certainty about nearer-term outlook..  Full Article

BRIEF-Addex and Indivior Sign Strategic Partnership

* REG-ADDEX AND INDIVIOR SIGN STRATEGIC PARTNERSHIP TO ACCELERATE DEVELOPMENT OF GABAB PAMS AS ADDICTION TREATMENTS